Tooth Filling Materials Market size to exceed $1.4bn by 2024

Tooth Filling Materials Market size is projected to exceed USD 1.4 billion by 2024; according to a new research report by Global Market Insights, Inc.

 

Increasing number of cosmetic dental procedures and consistent technological advancements for better and durable dental filing material will drive the global tooth filling materials market size.

Request for a sample of this research report – https://www.gminsights.com/request-sample/detail/816

Growing prevalence of dental disorders among geriatric population along with strong public awareness trends regarding oral hygiene have increased global number of dental procedures boosting the tooth filling materials market size. According to estimates, only 21% of adults visits the dentist annually whereas merely 42% of adults use toothbrush and toothpaste for oral hygiene.

Silver amalgam tooth filling material market size was valued at USD 360 million for 2015, and is expected to exceed USD 506 million by 2024, owing to its high durability and rising demand for cosmetic dental procedures. Glass ionomer is widely preferred among children for filling big tooth cavities owing to its color compatibility with teeth and associated minimal pain while filling. Continuous release of fluoride over time strengthens the teeth and maintains good dental health. Dental filling materials market will witness robust 4.3% CAGR and should exceed USD 215 million by 2024.

Browse key industry insights spread across 110 pages with 99 data tables & 6  figures& charts from the report, “Tooth Filling Materials Market Size by Product (Glass Ionomer, Silver Amalgam, Composite Fillings, Ceramic Fillings, Gold Fillings, Liners, Temporary Cements), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Russia, Poland, Japan, China, India, Australia, Malaysia, Thailand, Indonesia, Brazil, Argentina, Mexico, South Africa, Saudi Arabia, UAE, Qatar, Kuwait, Egypt), Growth Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2024” in detail along with the table of contents:

https://www.gminsights.com/industry-analysis/tooth-filling-materials-market

U.S. tooth filling materials market size was over USD 270 million in 2015. New product expansions and rising preference towards aesthetic dentistry will favor industry growth. According to the American Dental Hygienists Association (ADHA), about 78% of U.S. population have at least one cavity by age of 17, and 80% have periodontal gum disease.

Germany held over 26% of dental filling materials regional revenue share in 2015 and anticipated to surpass USD 83 million by 2024. The growing awareness regarding oral hygiene and increasing number of dental procedures in Europe will accelerate dental industry growth.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/816

China dental filling material market share attributed for over 41% of regional revenue share in 2015 due to rising prevalence of dental diseases and growing awareness for better dental care to avoid further dental complications.

About Global Market Insights:

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Web: https://www.gminsights.com
Blog: https://gminsights.wordpress.com
Connect with us: Facebook | Google+ | LinkedIn | Twitter

Infant Nutrition Market Analysis, Size, Applications Share, Trends & Forecast, 2017-2024

Infant Nutrition Market size is anticipated to witness lucrative growth over the forecast timeframe.High birth rate in developing regions should drive the infant nutrition market growth. Majority of the global population resides in developing countries where birth rates are highest. For instance, birth rate in developing economies such as India and Malaysia was about 19.9 and 16.8 per 1000 people respectively while it was approximately 12.5 and 12 per 1000 people in developed economies of U.S. and UK in 2014.

Rapid urbanization coupled with growth of middle class in developing regions will boost market growth. Increasing number of working mothers along with rising disposable incomes will further accelerate the infant nutrition market growth.

Request In-depth table of contents @ https://www.gminsights.com/request-toc/upcoming/1651

Presence of convenient packaging will increase infant nutrition market growth. Increasingly busy parental lifestyles have led to increased demand for conveniently packaged baby which are easy to transport such as pouches with plastic spouts at the top. Furthermore, the convenient packaging promotes self-feeding and independence among babies.

Increasing health consciousness amongst consumers has resulted in parents seeking natural, minimally processed baby foods which set their children up for a healthy lifestyle. Rising demand for organic baby foods will expand infant nutrition market.

However, concerns pertaining to risk of babies acquiring allergies from consumption of artificial infant formula and baby foods will impede market to some extent. Moreover, psychological block in the minds of parents regarding packaged baby foods will restrain growth.

Make Inquiry about this report @ https://www.gminsights.com/inquiry-before-buying/1651

Products for infant nutrition include infant formula and baby food. Infant formula segment encompasses infant milk formula, growing up milk formula, follow on milk formula and specialty baby formula. Infant milk formula held largest market share in 2015. Only breast milk can be viably substituted for infant milk formula. Absence of other alternatives to infant milk formula will serve to be as a high impact rendering factor. Presence of high birth rate in developing countries will further boost demand.  Growing up milk formula is anticipated to grow at a robust rate over the forecast period owing to increasing product awareness in developing economies coupled with increasing income levels of consumers.

Baby food includes prepared, dried and other baby foods. Continuous product innovations will boost segment growth over the forecast timeframe. However, presence of low birth rate and market saturation in developed countries will impede growth to some extent. Low penetration along with presence of high unmet needs, increasing birth rates and rising disposable incomes will increase market growth in developing regions.

On the basis of distribution channel, the infant nutrition market is segmented into online stores, specialty stores, supermarkets, pharmacy stores and others. Pharmacy stores dominated the market share in 2015.

India is predicted to grow at robust rate over the forecast period. Presence of high birth rate will serve to be a high impact rendering factor. Growing population of working women leading to greater adoption of infant formula and baby food owing to the convenience provided by them will escalate market growth. Economic development resulting in higher disposable incomes will further boost market growth.

Latin America infant nutrition market is anticipated to witness lucrative growth over the forecast period. Presence of high unmet needs coupled with high birth rates in countries such as Brazil, Mexico and Argentina will drive market growth in these countries. Increasing public awareness levels pertaining to infant formula and baby foods coupled with increasingly busy lifestyles and growth in number of working women will escalate demand.

Some of the industry players in infant nutrition market include Nestle, Mead Johnson & Company, Danone, Abbott, The Kraft Heinz company, Meiji Holdings, Beingmate Group, Synutra International Inc., Glanbia, Perrigo Company

The market players resort to various strategic initiatives such as new product launches, mergers and acquisitions to strengthen their foothold in the market and expand their product offerings. For instance, in July 2016, Danone entered into an agreement to acquire WhiteWave Foods for about USD 10 billion which will broaden the company’s product portfolio.

About Global Market Insights

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:

Arun Hegde

Corporate Sales, USA

Global Market Insights, Inc.

Phone: 1-302-846-7766

Toll Free: 1-888-689-0688

Email: sales@gminsights.com

Web: https://www.gminsights.com

Blog: https://gminsights.wordpress.com

Connect with us: Facebook | Google+ | LinkedIn | Twitter

Wearable Blood Glucose Monitoring Systems Market forecasters 2022 Product Overview and Scope, Share of Key Manufacturers

This report studies Wearable Blood Glucose Monitoring Systems in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.

Get Discount on this Report: https://marketsizeforecasters.com/enquire-for-discount/406494/?utm_source=abd-dc

Application, the market can be split into

  • Hospitals
  • ClinicsScope of the Report:

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.

Market Segment by TOP Manufacturers, this report covers:

  • Abbott
  • Medtronic
  • Hoffmann-La Roche
  • Bayer AG
  • Braun
  • Nipro Diagnostics
  • Life Scan Inc.(J&J)
  • Arkray Devices
  • Nova Biomedical
  • Bionime Corporation

 

Market Segment by Regions, regional analysis covers:

North America (USA, Canada and Mexico), Europe (Germany, France, UK, Russia and Italy), Asia-Pacific (China, Japan, Korea, India and Southeast Asia), South America (Brazil, Argentina, Columbia etc.), Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa).

Market Size forecasters presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

Report displays the production, revenue, price, market share and growth rate of each type, primarily split into

  • MIR/NIR
  • Raman Spectroscopy
  • Occlusion Spectroscopy
  • Optical Coherence Tomography
  • Electromagnetic
  • Fluorescence

Get Sample Copy of this Report: https://marketsizeforecasters.com/get-sample/406494/?utm_source=abd-dc

Market Size forecasters: List of Tables and Figures

Figure Picture of Wearable Blood Glucose Monitoring Systems

Table Product Specifications of Wearable Blood Glucose Monitoring Systems

Table Classification of Wearable Blood Glucose Monitoring Systems

Figure Global Production Market Share of Wearable Blood Glucose Monitoring Systems by Type in 2016

Figure MIR/NIR Picture

Table Major Manufacturers of MIR/NIR

Figure Raman Spectroscopy Picture

Table Major Manufacturers of Raman Spectroscopy

Figure Occlusion Spectroscopy Picture

Table Major Manufacturers of Occlusion Spectroscopy

Figure Optical Coherence Tomography Picture

Table Major Manufacturers of Optical Coherence Tomography

Figure Electromagnetic Picture

Table Major Manufacturers of Electromagnetic

Figure Fluorescence Picture

Table Major Manufacturers of Fluorescence

Figure Others Picture

Table Major Manufacturers of Others

Table Applications of Wearable Blood Glucose Monitoring Systems

Figure Global Consumption Volume Market Share of Wearable Blood Glucose Monitoring Systems by Application in 2016

Figure Hospitals Examples

Table Major Consumers in Hospitals

Figure Clinics Examples

Table Major Consumers in Clinics

Figure Others  Examples

Table Major Consumers in Others

Figure Market Share of Wearable Blood Glucose Monitoring Systems by Regions

………………………………

About Us:

MarketSizeForecasters.com, a Skyline Market Research LLP brand, is an online aggregator of market research reports. MarketSizeForecasters.com offers a comprehensive collection of full length reports on global and regional markets in 100+ industry verticals. We have partnered with some of the leading business and market research publishing houses and regularly update our online library to offer wide range of reports to our customers.

Contact Us:

Market size forecasters

The Green Suite #4594,

Dover, DE 19901

United States

Phone: 1-201-355-0868

US Toll Free: 1-866-764-2150

Email: sales@marketsizeforecasters.com

Website: http://marketsizeforecasters.com/

News: https://marketsizeforecasters.com/news 

Connect with us: LinkedIn | Twitter

For More Details On of this Report: https://marketsizeforecasters.com/global-wearable-blood-glucose-monitoring-systems-market-qy-research/?utm_source=abd-dc     

Related Report:

Global Thermal Ablation Devices Market Research Report 2017

The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges.

https://marketsizeforecasters.com/global-thermal-ablation-devices-market/?utm_source=abd-dc

Infection Control Market Analysis, Size, Applications Share, Trends & Forecast, 2017-2024

Infection Control Market size is set to grow substantially over the forecast time frame . Growing geriatric population along with increasing prevalence of chronic diseases such as cancer, diabetes, obesity, heart and respiratory disorders owing to lifestyle changes, lack of physical exercise, consumption of junk food and harmful substances such as alcohol and tobacco will drive future market growth. The elderly population is more prone to acquiring infections due to presence of combination of increased co morbid condition and decreasing activity of the immune system.

Request In-depth table of contents @ https://www.gminsights.com/request-toc/upcoming/1650

Rise in number of surgical procedures coupled with growing incidence of nosocomial infections will boost infection control market growth during the forecast period. As per WHO statistics, out of every 100 individuals hospitalized globally at any given time, 10 in developing countries and 7 in developed countries are likely to acquire nosocomial infections.

Increasing focus on sterilization of food and disinfection will further propel growth. Presence of various government and non-government initiatives pertaining to spreading awareness regarding need for disinfection and maintenance of proper hygiene will boost market expansion. For instance, ‘Save Lives: Clean your hands’ initiative aimed at spreading awareness regarding maintenance of hand hygiene globally.

Presence of strict regulatory policies pertaining to infection control agents will impede market growth to some extent. Moreover, saturation due to extensive use of these agents in developed economies will restrain growth in these regions.

Make Inquiry about this report @ https://www.gminsights.com/inquiry-before-buying/1650

Products for infection control encompass disinfection and sterilization products. Disinfection segment held largest market share in 2015. The segment includes disinfectants, endoscopic reprocessors, medical non-wovens and disinfectors. Sterilization methods include various sterilization methods such as heat, filtration, low temperature, radiation and contract sterilization services.

End users of infection control products include hospitals, life science companies, food industry, medical device companies and pharmaceutical companies among others. Hospital segment attributed for majority market share in 2015 owing to increasing number of surgical procedures and increasing prevalence of nosocomial infections.

U.S. infection control market held the largest share in 2016. The region is anticipated to follow a similar trend over the forecast time. Increasing geriatric population and growing prevalence of chronic diseases will boost regional market growth. As per Administration on Aging statistics, there were 46.2 million individuals aged 65 years and above in U.S. in 2014 and this population is expected to double in size by 2060. According to CDC, elderly people are more prone to chronic disease with three out of four individuals aged 65 years and above suffering from multiple chronic conditions. Increasing incidence of nosocomial infections coupled with rising awareness levels amongst public as well as health practitioners will further boost growth. Favorable government initiatives will further expand regional market growth.

India and China are anticipated to be fastest growing markets. Presence of large geriatric population and increasing prevalence of chronic diseases will serve to be high impact rendering factors. As per NHRSC statistics, chronic diseases accounted for 60 percent of deaths in India in 2014. Rapid economic development in these countries along with improvement in healthcare infrastructure will boost market growth. Growing need to maintain hygienic conditions in healthcare settings along with rising public awareness due to initiatives promoting usage of disinfection and sterilization techniques will further augment growth.

Some of the industry players include 3M Company, Belimed, Ahlstrom Corporation, Johnson & Johnson, Sterigenics International, Kimberly Clark Corporation, Steris, Getinge Group, Matachana Group, Cantel Medical Corporation.The market players opt for various strategic initiatives such as new product launches, mergers and acquisitions to broaden their product portfolio and strengthen their market position.

About Global Market Insights

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:

Arun Hegde

Corporate Sales, USA

Global Market Insights, Inc.

Phone: 1-302-846-7766

Toll Free: 1-888-689-0688

Email: sales@gminsights.com

Web: https://www.gminsights.com

Blog: https://gminsights.wordpress.com

Connect with us: Facebook | Google+ | LinkedIn | Twitter

Analysis of Insulin Delivery Devices Market applications and companies’ active in the industry

Insulin Delivery Devices Market size is expected to witness a considerable growth over the forecast period.
Increasing diabetes prevalence will drive insulin delivery devices market growth throughout the forecast period. As per the Centers for Disease Control and Prevention (CDC) about over 20 million people are stated to have diabetes. Obesity is linked to the prevalence of diabetes, thus leads to high diabetes prevalence. Growing population affected by diabetes should further drive the insulin delivery devices market size.

Growing diabetes awareness around the world through conferences, campaigns, and events educating about the complications and extended effects of diabetes, should encourage people to take their medications on time to avoid further health complications. Additionally, growing demand for developed insulin delivery devices is complementing the adoption of newly launched portable pumps devices and innovative pen.

Request In-depth table of contents @ https://www.gminsights.com/request-toc/upcoming/1649

Strict regulations governing the product approval process and government rules and the high price of insulin analogs in diabetes care management should hamper the market growth.

Insulin pens accounted for highest market share in 2016, owing to its benefits such as its user-friendly design, high adoption rate, and increasing acceptance amongst consumers. Rising focus of companies on product innovation should yield the high industry share. For example, Novo Nordisk launched a new device called NovoPen Echo in the U.S. It was the first device of its kind, with a half-unit dosage feature and memory function.

Make Inquiry about this report @ https://www.gminsights.com/inquiry-before-buying/1649

Homecare segment will continue to account for maximum market share during the forecast period. The significant factors resulting in substantial growth are growing adoption of insulin delivery devices and increasing awareness of diabetes care. Home usage of insulin devices saves additional visiting costs, clinic, or hospital fee, and waiting time. The developed devices including pens, pumps, and injectors, are small, highly portable, and give a comfort of using them anywhere and anytime. Therefore, better access to such delivery devices and their developed ease of usage has enabled insulin users opt for self-care diabetes management options.

U.S. insulin delivery devices market accounted for largest market share in 2016 owing to increasing awareness levels amongst the affected population. Increasing diabetic population and the availability of technologically advanced devices are the factors leading to the high market growth. Also, as per Canadian Diabetes Association, the prevalence of diabetes is increasing in Canada and it is projected to reach over 4 million by 2025. Forming a large patient base with diabetes and its growing incidence is likely to enhance the growth in the U.S. region for insulin delivery devices market during the forecast period.

India and China, are anticipated to witness significant growth during the forecast period due to the existence of a vast patient base suffering with diabetes and rising awareness of insulin delivery devices. In addition, large number of regional players are expanding their business by providing high-end products for diabetes care.

Companies operating in insulin delivery devices market include Novo Nordisk (Subsidiary of Novo A/S), Tandem Diabetes Care, Sanofi, Medtronic, Valeritas, Becton, Dickinson and Company, Eli Lilly, F. Hoffmann-La Roche, Ypsomed, Owen Mumford, Animas, Insulet Corporation, Asante Solutions (Now Bigfoot Biomedical), Abbott Laboratories, Biocon Ltd., Antares Pharma, Bioject Medical Technologies, Injex – Equidyne Systems, Tonghua Dongbao Pharmaceutical, Shanghai Fosun Pharmaceutical.

Technology innovation and product advancement initiatives are other major strategies adopted by the industry players to gain maximum market share. Industry players are growing their business with planned mergers and acquisitions and collaborations with other industry vendors. For example, in June 2014, Medtronic and Sanofi entered a tactical collaboration to develop drug-device combinations for diabetes patients. This association combined Medtronic’s proficiency in pump therapy and continuous glucose monitoring with Sanofi’s wide-ranging insulin product portfolio to advance upon type 2 diabetes care management and patient medication compliance.

About Global Market Insights

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:

Arun Hegde

Corporate Sales, USA

Global Market Insights, Inc.

Phone: 1-302-846-7766

Toll Free: 1-888-689-0688

Email: sales@gminsights.com

Web: https://www.gminsights.com

Blog: https://gminsights.wordpress.com

Connect with us: Facebook | Google+ | LinkedIn | Twitter

Preventive and Therapeutic Vaccine Market growth outlook with industry review and forecasts

Global Preventive and Therapeutic Vaccine Market size is poised to experience high growth, primarily because of its fast-growing nature and expanding market size. Vaccine developments have been considerably increasing since recent past and their adoption is also rising in various regions across the globe. Practices by the major companies, such as consistent research and innovation and development for introducing recent technologies to curb expense and reduce time will spur vaccine market worldwide.
Increasing government funding for vaccine development, rising R&D investments, the introduction of faster vaccine development technologies, and improvements in vaccine design are some of the factors, which will fuel market growth over the coming years. However, the high cost of vaccine storage and transportation and stringent regulations for the approval of vaccines will hamper the market expansion.

Request In-depth table of contents @ https://www.gminsights.com/request-toc/upcoming/1645

Global preventive and therapeutic vaccine market is broadly classified into preventive vaccine market and therapeutic vaccine market. Based on the product type, preventive vaccine market is segmented into pediatric and adult vaccines and therapeutic vaccine is segmented into neurological disease vaccines, autoimmune disease vaccines, infectious disease vaccines, and cancer vaccines.

Soaring prevalence of diseases among children is resulting in the implementation of awareness programs by governments across the globe. Moreover, significant advancements in vaccinology, such as the emergence, development, and usage of hepatitis B vaccine, should augment the business growth over the coming years.

Make Inquiry about this report @ https://www.gminsights.com/inquiry-before-buying/1645

Strategies adopted by major vendors in the market, such as the development of improved influenza vaccine that broaden vaccine-induced immunity, enhancing the vaccine immunogenicity, and introducing alternative delivery will result in greater adoption of influenza vaccine in future.

A significant factor proliferating the demand for certain vaccines is high effectiveness; for example, the experimental shingles vaccine protects about 90% of adults, the present Zostovax vaccine reduces the risk of shingles by about half and immunity wanes within five years. In coming years, more vaccines will have better effectiveness and therefore, these vaccines will experience high adoption rates.

Based on the technology type, the vaccine market is segmented into live attenuated, toxoid, conjugate, inactivated & subunit, and recombinant. The conjugate vaccines hold the largest market share; the growth of this segment is associated with the massive government support for vaccine development and rising investments in R&D.

The U.S. preventive and therapeutic vaccine market enjoys the major share because of the presence of advanced and active R&D establishment. It dominates the therapeutic vaccine market, which is driven by large pharmaceutical industry base, best-in-class healthcare infrastructure, and high spending on healthcare by the citizens. The government support for research and development of vaccines, investments for vaccine research, and ubiquity of different diseases fuel the growth of this region.

Europe preventive and therapeutic vaccine market is the second largest market after North America. Research, innovation, and development conducted by MNCs in the field of vaccine production by utilizing their deep expertise are advantages for this region. Increasing prevalence of diseases in children and adults will generate demand for more preventive vaccine in coming years; to cater to this demand, big companies, such as Pfizer, Merck, Sanofi, and GlaxoSmithKline, will play a key role in the future.

In the APAC preventive and therapeutic vaccine market, the growing incidences of cancer & HIV cases will give rise to the demand for vaccine and therefore boost the market growth. Improving healthcare sector, increasing healthcare expenditure, and government initiatives will render a high impact on adoption rates of vaccines. WHO estimates a huge potential for the market with the arrival of new improved preventive and therapeutic vaccines. China and India are expected to witness a boom in demand and are expected to attain maximum growth over the next 10 years, owing to the escalating prevalence of various infectious diseases and improving economic indicators.

Latin America therapeutic vaccines targeting cancers and allergies offer vast opportunities for fresh players entering this regional market. First FDA-approved therapeutic vaccine, Provenge by Dendreon, treating prostate cancer acknowledged the potential of vaccines in therapeutics. In the coming years, it is expected that the industry will experience improvements in vaccine delivery methodologies, vaccine design, manufacturing in a large-scale process, and development of personalized vaccines. Therapeutic vaccines address the demand for safe and cost-effective drugs for the treatment of cancer and HIV, fueling the market growth.

Saudi Arabia and South Africa dominates the Middle East & Africa preventive and therapeutic vaccine market. R&D funding for diseases, such as HIV and cancer, by the government offers a novel opportunity for the vaccine market. Wide usage of vaccines includes, inactivated, live attenuated, toxoid, subunit, conjugate, dendritic cell, and synthetic. Preventive vaccine is the leading type due to high awareness among people.

Some of the major players in the global preventive and therapeutic vaccine market are Sanofi Pasteur, Merck & Co., Pfizer, and GlaxoSmithKline. The largest players account for approximately 80% of the global revenue. AstraZeneca, Johnson & Johnson, CSL, and Emergent Biosolutions are the other notable industry players.

About Global Market Insights

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:

Arun Hegde

Corporate Sales, USA

Global Market Insights, Inc.

Phone: 1-302-846-7766

Toll Free: 1-888-689-0688

Email: sales@gminsights.com

Web: https://www.gminsights.com

Blog: https://gminsights.wordpress.com

Connect with us: Facebook | Google+ | LinkedIn | Twitter

Chemical Analyzers Market Size, Share, Price Trend | Industry Report

Chemical Analyzers Market size is set to witness healthy gains in the coming years. Growing geriatric population across the globe will be the high impact rendering factor for the chemical analyzers market.

Geriatric population (aged 65 and older) forms 7% of the total world population. In Japan, about 33% of the population was aged over 60, while in Germany and Italy, about 28% of the population was over 60 as of 2015. These elderly patients are prone to lifestyle diseases, such as heart-related diseases, and requires regular medical checkup.

Growing incidences and prevalence of lifestyle diseases are predicted to drive the market over the forecast period. Lifestyle diseases, such as heart disease and diabetes, are the leading causes of death and disability across the globe. Chemical analyzers reduce the burden of such diseases by providing early and accurate diagnosis. Chemical analyzers further help in understanding the causal factors and disease function, which enables the prevention of diseases.

Request In-depth table of contents @ https://www.gminsights.com/request-toc/upcoming/1644

The launch of technologically advanced products in the market has improved user convenience. Time and cost-effective instruments are being launched in the market with high-throughput and increased analytical range. For instance, Roche launched cobas c 513 analyzer, to address the growing demand for HbA1c testing of patients with diabetes. The newly launched analyzer minimizes the risk by providing accurate results in lesser time.

However, the high cost associated with chemical analyzers is predicted to impede the industry growth over the forecast period.

Chemical analyzers are used to detect the concentration of electrolyte, lipid, cholesterol, glucose, calcium, carbohydrate, protein, and other molecules in bodily fluids, such as blood, plasma, urine, and serum. The analyzers aid in the diagnosis and treatment of a wide range of diseases including heart diseases, hepatitis, cancer, diabetes, thyroid problems, HIV, and STD.

Make Inquiry about this report @ https://www.gminsights.com/inquiry-before-buying/1644

Chemical analyzer instruments include various automated and semi-automated instruments that perform the analysis of biological fluids such as blood, serum, saliva, and urine. These instruments vary in size and capability of performing number of tests per hour. A biological sample is mixed with different reagents prior to loading in analyzer. Reagents chemically react with the components to be analyzed and produces color. The instrument measures the intensity or wavelength absorbed by the color to determine the concentration of target elements.

Chemistry panels include tests that are performed to determine the health status of patients. Different chemistry panels consist of Basic Metabolic Panel, Comprehensive Metabolic Panel, Comprehensive Metabolic Panel, Electrolyte Panel, Liver Panel, Renal Panel, and Thyroid Function Panel.

Basic metabolic panel is expected to dominate the market due to the high prevalence of metabolic abnormalities and lifestyle diseases. In this test, patient’s blood is analyzed to measure quantitatively the presence of glucose, electrolyte, and kidney functions. It also enables monitoring the effects of administered drugs, such as diuretics.

Similarly, liver panel is a test performed to determine the presence of liver inflammation, liver infection, and other liver-related diseases and lipid profile test is used to assess the risk of developing cardiovascular diseases.

Hospitals are using chemical analyzers for diagnosis diseases, such as heart disease, diabetes, and HIV. Growing incidences and prevalence of such diseases is expected to escalate the use of chemical analyzers by hospitals. Further, hospitals are preferring high-throughput automated analyzers that reduce the time required to perform the analysis and provide accurate results with minimum cost.

The U.S. witnessed a significant rise in the geriatric population and prevalence of lifestyle diseases, such as cancer, heart disease, and diabetes. Moreover, this prevalence is expected to grow further. For instance, 29.1 million people in the U.S were diagnosed with diabetes in 2014. Demand for chemical analyzers is predicted to remain high owing to the need for the early detection of such diseases.

APAC exhibits a high prevalence of lifestyle diseases driving the regional market growth. For instance, annually over 5.8 million deaths occurred in India from heart and lung diseases, stroke, cancer, and diabetes.

Some of the key industry players operating in chemical analyzers market include Danaher Corporation, Mindray Medical International, Thermo Fisher Scientific, Abbott Laboratories, Johnson & Johnson, Siemens, F.Hoffmann-La Roche, Elitech, Carolina Liquid Chemistries, Randox Laboratories, and Nova Biomedical.

About Global Market Insights

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:

Arun Hegde

Corporate Sales, USA

Global Market Insights, Inc.

Phone: 1-302-846-7766

Toll Free: 1-888-689-0688

Email: sales@gminsights.com

Web: https://www.gminsights.com

Blog: https://gminsights.wordpress.com

Connect with us: Facebook | Google+ | LinkedIn | Twitter

Bioabsorbable Vascular Stents Market growth outlook with industry review and forecasts

Bioabsorbable Vascular Stents Market size is expected to witness lucrative growth in the period 2017-2024. Bioabsorbable vascular stents can be disintegrated by human body without external intervention. Hence, they eliminate the need for post-treatment involvements and prevent inflammation leading to stent restenosis and thrombosis. Bioabsorbable stents avoid stent-in-stent procedures and cut the need for dual antiplatelet therapies; thus, increasing the demand for bioabsorbable stents.

Request In-depth table of contents @ https://www.gminsights.com/request-toc/upcoming/1643

Global bioabsorbable vascular stents market is strongly driven by escalating growth in geriatric population, rising incidences of cardiac ailments, coronary & peripheral artery diseases, and increasing number of obese people. Furthermore, promising product pipelines and rising technological advancements will boost the business growth.

However, slow adoption rate of stents in disease management, inadequate reimbursement policies, stringent regulatory scenario, and the presence of substitutes will hamper the market growth.

Based on the material type, the market is segmented into polymer-based and metal-based bioabsorbable stents. The polymer-based stents market is set to witness a higher growth than metallic bioabsorbable stents due to its comparative advantages over metallic type.

Make Inquiry about this report @ https://www.gminsights.com/inquiry-before-buying/1643

By application type, the market is segmented into coronary and peripheral artery stent. The coronary artery stents hold a major market share and are expected to continue their dominance in the coming years owing to the healthcare industry’s objective to reduce deaths due to cardiovascular diseases. Preferences of cardiologists toward coronary intervention procedures are expected to make significant revenue from this segment during the forecast period.

The rising incidence of peripheral artery disease propels the demand for peripheral stents. Escalating geriatric population is another factor responsible for the rise in demand for peripheral stents. The development of imaging techniques improved the surgeries involving the placement of peripheral vascular stents and owing to this, there will be an anticipated increase in stenting procedures. However, high price and low awareness of the peripheral stents among the general population about peripheral vascular diseases are expected to hamper the revenue growth.

By end use, the type of bioabsorbable vascular stents market is segmented into hospitals and cardiac centers. The factors that result in a higher market value of hospital segment is the advanced medical infrastructure and trained professionals to cater to the needs of people, which are not usually seen in cardiac centers and small clinics. The hospital segment dominated the market during 2016 in terms of revenue and will continue to lead until the end of 2021.

North America region dominates the global bioabsorbable stents market. Technological advancements and increased awareness about the treatment of coronary ailments in bioabsorbable stents support the growth of this market. The U.S. represents the largest market for bioabsorbable stents; however, due to the stringent regulatory scenario of the FDA, only one product (Abbott Absorb) is available in the U.S. However, many products are in the clinical pipeline and in the developmental phase, which is an indicator of bright future of this market.

Europe holds the second largest revenue share. Increasing aging population, unhealthy lifestyle habits, and the strong healthcare infrastructure are the major driving factors. Regions such as Germany, France, and the UK are some of the early adopters of advanced technology, therefore, the adoption of bioabsorbable vascular stents in these countries should be high resulting in the high growth of this market in coming years.

APAC bioabsorbable vascular stents market is poised to witness high growth rate in coming years. Increasing public awareness about various coronary and peripheral artery diseases in the region will primarily generate the demand for stents. Japan, South Korea, Australia, China, and India are poised to experience high growth rate. Favorable government policies are expected to create a broader customer base in countries, such as India, where stents prices are capped at 40% lesser than the company’s set prices. Moreover, approval of new stents in Asia will also augment the market growth. Recently, Meril Life Sciences bioresorbable vascular scaffold got the official government approval to market the stent. Asia Pacific region is likely to be the fastest growing region due to opportunities for growth, rising prevalence of lifestyle diseases, and entering of new investors in the interventional cardiology market.

Saudi Arabia and South Africa dominates the Middle East and Africa bioabsorbable vascular stents market. Increasing initiatives by the public and private sectors in South Africa along with the introduction of new stent products will fuel the bioabsorbable stents market growth in coming years.

Some of the key vendors in global bioabsorbable stents market are Medtronic, Abbott Laboratories, Boston Scientific Corporation, Biosensors International Group, Ltd., BIOTRONIK SE & Co., KG, Meril Life Sciences Pvt. Ltd., and Kyoto Medical Planning Co., Ltd.

About Global Market Insights

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:

Arun Hegde

Corporate Sales, USA

Global Market Insights, Inc.

Phone: 1-302-846-7766

Toll Free: 1-888-689-0688

Email: sales@gminsights.com

Web: https://www.gminsights.com

Blog: https://gminsights.wordpress.com

Connect with us: Facebook | Google+ | LinkedIn | Twitter

Drug-Eluting Bioabsorbable Stents Market drivers of growth analysed in a new research report

Global Drug-Eluting Bioabsorbable Stents Market size is driven by the increasing geriatric population, rising obesity rate and associated risk factors, and development of technologically advanced devices. As per UN estimates, the global population above 60 years is expected to double by 2050. Rising geriatric population will accelerate the demand for drug-eluting bioabsorbable stents over the forecast period.

Request In-depth table of contents @ https://www.gminsights.com/request-toc/upcoming/1383

The obese population is susceptible to chronic diseases such as coronary heart diseases, diabetes, and high BP, strongly influencing the business growth. Furthermore, the rise in the number of cardiac surgeries is playing a vital role in attracting the patients toward drug eluting bioabsorbable stents. Drug-eluting stents with bioabsorbable polymer coating reduce the incidence of vessel revascularization and coronary restenosis, making it a better option over the traditional bare metallic stents. It is another prominent factor fueling the demand for these stents. On the other hand, high purchase cost of these devices is a major factor impeding market growth. Further, risk factors post DES implantation, such as chronic wall inflammation and endothelial dysfunction leading to stent thrombosis, are restraining the market size.

Drug eluting bioabsorbable stents market is segmented based on product, material, application, end-user, and region. By product type, the market is segmented into serolimus and paclitaxel drug-eluting stents. Sirolimus drug eluting stents with biodegradable polymer coating is expected to lead the market due to its advantages such as reduced incidence of Target Vessel Failure (TVF) and Major Adverse Cardiac Events (MACE). Paclitaxel stents segment will show a healthy growth rate over the coming years.

Make Inquiry about this report @ https://www.gminsights.com/inquiry-before-buying/1383

Based on the material, the industry is bifurcated into metallic and polymerbased drug eluting stents. Polymer based stents with biodegradable poly lactide coating will be naturally absorbed and metabolized in the body. This factor should boost the demand for polymeric stents over metallic stents.

Based on the application, the market is categorized into coronary artery diseases and peripheral artery diseases. The coronary segment is leading the market and will continue to witness a tremendous growth in the future due to the growing elderly patient pool, increasing prevalence of obesity, escalating number of deaths due to cardiac diseases, and increasing coronary interventions procedures.

Rising incidence of peripheral artery disease propels the demand for peripheral drug eluting stents. Rising geriatric population and technological innovations in this field are factors responsible for the increased demand for peripheral stents. However, the high cost of devices and complications associated with stents will hamper this segment’s growth.

By end-user, the market is segmented into hospitals and cardiac centers. The hospital segment dominates the market in terms of revenue and will continue to lead in the future. This is attributed to established medical infrastructure along with highly skilled and trained professionals to cater to the needs of patients suffering from coronary and peripheral artery diseases.

Europe dominates the drug eluting bioabsorbable stents market followed by North America. Increasing aged population, established healthcare infrastructure, and rising awareness among patients for these devices in developed countries, such as Germany, the UK, and France, will accelerate the market size.

U.S. drug eluting bioabsorbable stents market will witness a significant growth over the coming years. Increasing prevalence of coronary artery diseases, sedentary lifestyle, and growing elderly population base will fuel the demand for drug eluting stents. Giant players, such as Abbott and  Biosensors International, are developing innovative bioabsorbable stents to reduce the complications post percutaneous coronary intervention procedures.

APAC is poised to be the fastest growing drug eluting bioabsorbable stents market over the forecast timeline. Developing economies, such as India, China, and Japan, will witness a tremendous growth owing to the increasing elderly patient pool, rising prevalence of obesity leading to cardiac diseases, and rising government initiatives. These factors will fuel bioabsorbable stents’ demand in the future.

Some of the prominent players in this market include Medtronic, B.Braun Melsungen, Abbott Laboratories, Boston Scientific Corporation, Medtronic, Biosensors International, and Terumo Corporation. To expand the product portfolio and capture higher market share, these players are focusing on unique growth strategies such as acquisitions, mergers, and new product launches.

Some of the other notable industry vendors are MicroPort Scientific Corporation, Alvimedica, Biotronik, Elixir Medical Corporation, and Innovative Health Technologies. These players are adopting collaborations and geographic expansion growth strategies to enhance their manufacturing capabilities as well as increasing their presence across the globe.

About Global Market Insights

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:

Arun Hegde

Corporate Sales, USA

Global Market Insights, Inc.

Phone: 1-302-846-7766

Toll Free: 1-888-689-0688

Email: sales@gminsights.com

Web: https://www.gminsights.com

Blog: https://gminsights.wordpress.com

Connect with us: Facebook | Google+ | LinkedIn | Twitter

Genitourinary Drugs Market Analysis, Size, Applications Share, Trends & Forecast, 2016-2024

Genitourinary Drugs Market size will witness a considerable growth over the forecast period.Increasing prevalence of genitourinary disorders, rising disposable incomes, and constant improvements in healthcare infrastructure will drive genitourinary drugs market over the forecast timeframe.

Patients with diabetes are highly susceptible to suffer from urinary tract infections. Women are more disposed to this problem due to the short length of urethra that facilitates easier entry of microorganisms. Global prevalence of diabetes is projected to reach up to 552 million by 2030 from 366 million in 2011, as per the statistics by International Diabetes Federation. Tremendous growth in diabetes prevalence should also boost the demand for genitourinary drugs over the coming years.

Request In-depth table of contents @ https://www.gminsights.com/request-toc/upcoming/1382

Lack of therapy compliance and continual patent expirations may hamper the overall genitourinary drugs market growth. Invasion of a wide range of generics by major- and medium-sized pharmaceutical companies is likely to constrain the industry growth.

Prostate cancer contributed to over 25% revenue share in 2015. A wide range of therapeutics, such as radiopharmaceuticals, immunotherapy medication, and anti-neoplastic agents, available to treat prostate cancer will drive this segment’s growth. According to National Cancer Institute (NCI), the total number of new prostate cancer cases between 2009 to 2013 were 129.4 per 100,000 men every year.

Urinary Tract Infections (UTIs) affect more than 150 million people every year worldwide, resulting in direct healthcare expenses of over USD 6 billion. Around 2.4 percent of women and men will be detected with bladder cancer at some point during their lifetime.

Hormonal therapy dominated the segment in 2015 due to increasing usage of medicines; however, anti-infective drugs should witness a healthy growth over the forecast period with increasing rate of urinary tract infections. The presence of an extensive drug pipeline for reproductive disorders in women may boost sales of the gynecological products over the coming years.

Make Inquiry about this report @ https://www.gminsights.com/inquiry-before-buying/1382

U.S. genitourinary drugs market size held a large share of the global genitourinary drugs in 2015 due to robust healthcare infrastructure, growing awareness, and technological advancements in the development of genitourinary drugs.

Canada genitourinary drugs market share is driving due to the burden of cancer disease in the country.  As per the Canadian Cancer Statistics in 2015, about 196,900 people diagnosed with cancer.The data is important  to focus on prevention efforts, in both primary prevention  and secondary prevention  of cancer, and allow more effective treatment of certain cancer through earlier detection.

Europe genitourinary drugs market will witness a significant growth over the forecast timeframe. It was estimated that over 78% of the new cancer medicines that were introduced between 2010 and 2014 are available within the greater EU. In 2012, Germany’s GDP accounted for over USD 34,706.8 per capita, driving the industry growth.

APAC should witness a lucrative growth during the forecast period owing to the increasing R&D in China and India, high disposable income, and growing awareness in these emerging countries.

Some of the companies operating in this industry include Abbott Laboratories, Astellas, Bayer, Bristol-Myers Squibb, Eli Lilly, Pfizer, Genentech, GlaxoSmithKline, Merck, Hoffman-La Roche, Immunex, and Ionis Pharmaceuticals.

High R&D expenditure by global players will drive industry innovation. Industry participants are developing novel products to gain competitive market leverage over their peers.

Companies are focusing on the implementation of strategies including mergers & acquisitions, new product development, and regional expansion. In October 2016, the U.S. FDA approved a supplemental Biologics License Application (sBLA) of Bristol-Myers Squibb, to enlarge the practice of Opdivo (nivolumab) to treat patients suffering from an advanced form of bladder cancer. Similarly, in June 2016, the U.S. National Surgical Adjuvant Breast and Bowel Project (NSABP) and Bayer, collaborated on a new Phase III trial to study Stivarga (regorafenib) tablets as an adjuvant therapy in colon cancer. Growing geographical presence of the industry players is expected to raise the awareness levels regarding  treatment options  for genitourinary diseases among the patients and  the doctors.

About Global Market Insights

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:

Arun Hegde

Corporate Sales, USA

Global Market Insights, Inc.

Phone: 1-302-846-7766

Toll Free: 1-888-689-0688

Email: sales@gminsights.com

Web: https://www.gminsights.com

Blog: https://gminsights.wordpress.com

Connect with us: Facebook | Google+ | LinkedIn | Twitter